Myeloid- derived suppressor cells (MDSCs) Mediated Tumor Targeting

Description:

Thank you for your interest in this technology. Please see our technology brief here: https://app.in-part.com/articles/q9n7e86e06mA

Patent Information:
Category(s):
Therapeutic
For Information, Contact:
Kevin Sharpe
Assistant Director, Business Development and Licensing
Icahn School of Medicine at Mount Sinai
kevin.sharpe@mssm.edu
Inventors:
Shu-Hsia Chen
Keywords:
Oncology
© 2019. All Rights Reserved. Powered by Inteum